For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Exact Sciences Corp.’s stock clocked out at $59.48, down -3.14% from its previous closing price of $61.41. In other words, the price has decreased by -$3.14 from its previous closing price. On the day, 3.4 million shares were traded. EXAS stock price reached its highest trading level at $62.265 during the session, while it also had its lowest trading level at $59.04.
Ratios:
To gain a deeper understanding of EXAS’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.06 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 342.48. For the most recent quarter (mrq), Quick Ratio is recorded 2.07 and its Current Ratio is at 2.32. In the meantime, Its Debt-to-Equity ratio is 0.82 whereas as Long-Term Debt/Eq ratio is at 0.79.
On December 14, 2023, Guggenheim started tracking the stock assigning a Buy rating and target price of $90.
On December 13, 2023, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $95.Wolfe Research initiated its Outperform rating on December 13, 2023, with a $95 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 01 ’24 when Conroy Kevin T sold 1,155 shares for $60.15 per share. The transaction valued at 69,473 led to the insider holds 1,156,191 shares of the business.
Cunningham Everett sold 136 shares of EXAS for $8,180 on May 01 ’24. The Chief Commercial Officer now owns 47,042 shares after completing the transaction at $60.15 per share. On May 01 ’24, another insider, Elliott Jeffrey Thomas, who serves as the Chief Financial Officer of the company, sold 136 shares for $60.15 each. As a result, the insider received 8,180 and left with 11,795 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXAS now has a Market Capitalization of 10935398400 and an Enterprise Value of 12936797184. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.37 while its Price-to-Book (P/B) ratio in mrq is 3.43. Its current Enterprise Value per Revenue stands at 5.175 whereas that against EBITDA is -126.55.
Stock Price History:
Over the past 52 weeks, EXAS has reached a high of $100.77, while it has fallen to a 52-week low of $56.05. The 50-Day Moving Average of the stock is -6.09%, while the 200-Day Moving Average is calculated to be -13.59%.
Shares Statistics:
It appears that EXAS traded 2.49M shares on average per day over the past three months and 2075930 shares per day over the past ten days. A total of 183.85M shares are outstanding, with a floating share count of 181.94M. Insiders hold about 1.04% of the company’s shares, while institutions hold 84.73% stake in the company. Shares short for EXAS as of 1713139200 were 9892023 with a Short Ratio of 3.98, compared to 1710460800 on 6518992. Therefore, it implies a Short% of Shares Outstanding of 9892023 and a Short% of Float of 5.43.
